Stephen Zicha is a senior leader in neuroscience R&D with extensive experience in drug discovery and development, particularly in translational sciences. Zicha has held significant roles at organizations such as Quartet Medicine, AstraZeneca, and Takeda, leading teams that focus on biomarker discovery and the development of novel therapeutic strategies for neurological conditions. Currently, Zicha is a Senior Director in Neuroscience at Eli Lilly and Company, where they are involved in evaluating external opportunities and collaborations. Zicha's educational background includes an Executive Leadership program at Harvard Medical School, further enhancing their capability to drive innovation in the biopharmaceutical industry.
This person is not in any teams
This person is not in any offices